Dr Martens PLC - London-based footwear manufacturer - Permira V Fund restructures its holding of shares in Dr Martens. IngreGrsy Ltd, a newly incorporated Guernsey company, replaces IngreLux Sarl, a Luxembourg entity, in the Permira Fund V structure and IngreLux Sarl transfers its 38% shareholding in Dr Martens to IngreGrsy Ltd. As a result, IngreGrsy Ltd replaces IngreLux Sarl as the DM’s largest shareholder with effect from Tuesday. The Permira V Fund ownership structure is otherwise unchanged and remains ultimately controlled by Permira V GP Ltd and advised by Permira Advisers LLP.

Current stock price: 85.05 pence

12-month change: down 35%

Copyright 2024 Alliance News Ltd. All Rights Reserved.